[{"Assets_0_Q2_USD":137473000.0,"CommonStockSharesOutstanding_0_Q2_shares":21217494.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-30536000.0,"NetIncomeLoss_2_Q2_USD":-16324000.0,"NetIncomeLoss_1_Q2_USD":-8663000.0,"StockholdersEquity_0_Q2_USD":107662000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]